Challenger Limited

Equities

CGF

AU000000CGF5

Life & Health Insurance

Market Closed - Australian S.E. 02:10:44 2024-04-19 am EDT 5-day change 1st Jan Change
6.65 AUD -2.49% Intraday chart for Challenger Limited -1.48% +2.47%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Challenger's Assets Under Management Rise 6% in Fiscal Q3; Upgrades Guidance MT
New Zealand Shares Decline on Monday; Heartland Group Secures Regulatory Approvals to Acquire Challenger Bank MT
Heartland Group Receives Regulatory Approvals for Challenger Bank Acquisition; Begins NZ$210 Million Raise MT
Jarden Research Adjusts Challenger Limited’s Price Target to AU$7.55 From AU$7.25, Keeps at Overweight MT
Transcript : Challenger Limited, H1 2024 Earnings Call, Feb 13, 2024
Challenger Posts 80% Jump in Fiscal H1 Net Profit MT
Challenger Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI
Challenger Limited Declares Interim Dividend for the Six Months Ended 31 December 2023, Payable on 19 March 2024 CI
Transcript : Challenger Limited - Special Call
Challenger Limited Announces Quarterly Dividend of One Quarter Ended February 25, 2024, Payable on February 26, 2024 CI
Challenger Limited Announces Quarterly Dividend Ended February 26, 2024, Payable on February 25, 2024 CI
Challenger Expands Relationship with Apollo Global Management MT
Challenger Limited Appoints Matthew Michelini as Director CI
Challenger Limited and Challenger Life Company Limited Announce the Appointment of Lisa Gray as Independent Non-Executive Director, Effective 9 November 2023 CI
Transcript : Challenger Limited - Shareholder/Analyst Call
Challenger Limited Announces Board Changes CI
Challenger Limited Declares Ordinary Dividend for the Six Months Period Ended 30 June 2023, Payable on 20 September 2023 CI
Challenger Raises Final Dividend as Fiscal 2023 Profit Grows; Shares Fall 6% MT
Transcript : Challenger Limited, 2023 Earnings Call, Aug 15, 2023
Challenger Limited Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Challenger Limited Declares Dividend for the Six Months Period Ended 30 June 2023, Payable on September 20, 2023 CI
Challenger to Provide De-Risking Service for Aware Super's Fund MT
Challenger Completes Sale of Australian Real Estate Business MT
Elanor Investors Limited and Elanor Investment Fund completed the acquisition of Challenger Real Estate from Challenger Limited. CI
Pacific Current Group Sells Investment in Proterra Investment Partners Asia to Challenger Funds Management MT
Chart Challenger Limited
More charts
Challenger Limited is an Australia-based investment management company. The Company operates through two segments: Life and Funds Management. The Life segment principally includes the annuity and life insurance business carried out by Challenger Life Company (CLC). CLC offers fixed-rate and other retirement and superannuation products that are designed for Australian investors who are seeking a low-risk, fixed-term, or lifetime investment and reliable income. CLC also offers fixed-term and lifetime investments to investors in Japan through its reinsurance arrangement with Mitsui Sumitomo Primary Life Insurance Company Limited (MS Primary). CLC invests in assets that provide long-term income streams for customers. Its Funds Management segment is engaged in providing an end-to-end fund management business. The Funds Management segment also offers a range of managed investments across fixed income and property.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
6.65 AUD
Average target price
7.537 AUD
Spread / Average Target
+13.35%
Consensus
  1. Stock Market
  2. Equities
  3. CGF Stock
  4. News Challenger Limited
  5. Challenger : Fiscal Net Profit Slips 10% in July-December 2020 from Prior Half; Shares Tumble 10%